Abbott Laboratories
ABT
NZ$219.77
Share price
0.10%
Change (1 day)
29.78%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Market capitalization of Abbott Laboratories (ABT)
Market cap: NZ$382.37 Billion
As of June 2025 Abbott Laboratories has a market cap of NZ$382.37 Billion. This makes Abbott Laboratories the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Abbott Laboratories from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$382.37 B | 8.12% |
| 2024 | NZ$353.64 B | 17.04% |
| 2023 | NZ$302.16 B | 0.22% |
| 2022 | NZ$301.50 B | -17.25% |
| 2021 | NZ$364.35 B | 35.47% |
| 2020 | NZ$268.94 B | 18.32% |
| 2019 | NZ$227.31 B | 20.07% |
| 2018 | NZ$189.31 B | 35.35% |
| 2017 | NZ$139.87 B | 71.32% |
| 2016 | NZ$81.64 B | -15.52% |
| 2015 | NZ$96.63 B | 11.52% |
| 2014 | NZ$86.65 B | 20% |
| 2013 | NZ$72.20 B | -42.48% |
| 2012 | NZ$125.53 B | 11.85% |
| 2011 | NZ$112.23 B | 16.83% |
| 2010 | NZ$96.06 B | -16.68% |
| 2009 | NZ$115.30 B | -19.2% |
| 2008 | NZ$142.69 B | 25.6% |
| 2007 | NZ$113.61 B | 6.89% |
| 2006 | NZ$106.28 B | 19.7% |
| 2005 | NZ$88.79 B | -12.94% |
| 2004 | NZ$101.98 B | -9.48% |
| 2003 | NZ$112.67 B | -6.12% |
| 2002 | NZ$120.02 B | -42.76% |
| 2001 | NZ$209.68 B | 24.09% |
| 2000 | NZ$168.97 B | 57.19% |
| 1999 | NZ$107.49 B | -23.74% |
| 1998 | NZ$140.96 B | 63.44% |
| 1997 | NZ$86.24 B | 53.14% |
| 1996 | NZ$56.31 B |
End of Day market cap according to different sources
On Jun 18th, 2025 the market cap of Abbott Laboratories was reported to be:
NZ$382.31 Billion
NZ$382.37 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | NZ$608.54 B | 59.15% | 🇺🇸 USA |
 Pfizer PFE | NZ$226.47 B | -40.77% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | NZ$245.96 B | -35.67% | 🇺🇸 USA |
 Hologic HOLX | NZ$23.72 B | -93.80% | 🇺🇸 USA |
 Medtronic MDT | NZ$183.34 B | -52.05% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | NZ$159.53 B | -58.28% | 🇺🇸 USA |
 Boston Scientific BSX | NZ$249.80 B | -34.67% | 🇺🇸 USA |
 AstraZeneca AZN | NZ$377.47 B | -1.28% | 🇬🇧 UK |
 Novartis NVS | NZ$384.94 B | 0.67% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | NZ$131.76 B | -65.54% | 🇬🇧 UK |